Ethnic and geographic diversity of BRCA1/2 variants: a narrative review of pathogenic variants and VUS

Read full text Summarise with VIRAT
Authors: Masatake Hara, Ritsuko Sasaki, Tomoyuki Aruga, Masakazu Toi
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background and Objective: Breast cancer is the most prevalent malignancy among adult women, exhibiting diverse incidence rates and clinical characteristics across different ethnic groups. Germline pathogenic variants (PVs) in BRCA1 and BRCA2 are significant contributors to hereditary breast cancer (HBC); however, their prevalence and characteristics vary considerably across global populations, resulting in knowledge gaps that impede equitable clinical care in these populations. This narrative review synthesizes the latest evidence on the ethnic and geographic diversity of BRCA1/2 PVs and variants of uncertain significance (VUS) to elucidate their clinical implications. Methods: A comprehensive literature search was conducted using PubMed, MEDLINE, and Google Scholar for studies published up to January 2026, with the search restricted to English-language publications. The search terms included “BRCA1”, “BRCA2”, “prevalence”, “founder mutation”, “VUS”, “BCCR”, and terms for various ethnicities and geographic regions. Recent large-scale population-based studies were prioritized, supplemented by hand searches of reference lists and international databases such as Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and ClinVar. Key Content and Findings: This review delineates the global landscape of BRCA1/2 variations based on the latest cohort studies and international databases. In unselected breast cancer cohorts, PV prevalence ranges from 1.8% to 9.5%, with the highest rates observed among Ashkenazi Jewish populations (3.4–9.5%) and lower rates among Europeans (1.8–2.6%), North Americans (2.1%), and East Asians (0.9–5.4%). Mutation spectra, including single-nucleotide variants, small indels, and large genomic rearrangements (LGRs), exhibit significant ethnic variability, with notable founder mutations identified in several populations. VUS rates have declined to

Fields of Study & Subjects

BRCA gene mutations in cancer Genetic factors in colorectal cancer Breast Lesions and Carcinomas

Publication details

Journal / source
Breast Communications
Volume
2
Pages
6–6
Publication date
1 March 2026
Language
EN